Updated/Latest Little and Falace's Dental Management of the Medically Compromised Patient 9th Edition James W. Little Craig S. Miller Nelson L. Rhodus Test Bank Complete Chapters 1–30 Comprehensive Dental Management Resource Practice Questions Answ

,Chapter 01: Information Sources, Regulatory Agencies, Drug Legislation, and Prescription
L
YFT YFTL YFT L YFT L YFT L YFT L YFT L YFT L L
YFT




Writing
YFT L



Haveles: Applied Pharmacology for the Dental Hygienist, 9th Edition
L
YF
T L
YF
T YF
TL YF
T L YF
T L YFT L YF
TL L
YF
T




MULTIPLE CHOICE YFT L




1. Knowledge of pharmacology aids the dental professional in YFT L YFT L YFT L L
YFT YFT L Y FT L YF T L



a. obtaining a patient’s health history. YFTL YFTL YFT L L
YF T




b. administering drugs in the office. L
YFT Y FT L YFTL YFT L



c. handling emergency situations. YFT L L
YFT




d. selection of a nonprescription medication. YFT L YFT L YFT L Y FT L



e. All of the above. YF T L YF T L L
YFT




ANS: Y F T L E
All of the choices are true. Because many of our patients are being treated with drugs, knowledge
YF T L YF T L YF T L Y FT L YF TL L
YFT YFT L YFT L Y FT L L
YFT YFT L YF T L L
YF T L
YFT L
YF T YF TL



of pharmacology helps in understanding and interpreting patients’ responses to health history
YFT L Y FT L L
YFT L
YFT YFT L L
YFT YFT L YFT L L
YFT L
YFT YFT L L
YFT




questions. Knowledge of the therapeutic and adverse effects of medications obviously helps in
L
YFT YFT L YF T L Y FT L YF TL YFT L Y FT L YFT L YFT L Y FT L YFT L Y FT L Y FT L



their proper administration in the office. Emergency situations may be caused by drugs or treated
YFT L YF T L YFT L YFT L YF T L YFT L YFT L Y FT L Y FT L YF T L YF T L Y FT L YF T L YFT L L
YFT




by drugs; thus, knowledge of pharmacology is of great help, especially because a rapid response
YFT L YFT L YF T L YFT L Y FT L YFT L YF T L L
YF T YF TL YFT L YFT L L
YF T Y FT L YF T L Y FT L



is sometimes required. A clear understanding of the concepts of drug action, drug handling by the
YFT L L
YF T Y FT L YF T L YFT L YF T L L
YF T YF T L YFT L YFT L L
YF T YF T L YFT L YFT L YF T L Y FT L



body, and drug interactions will allow the dental practitioner to make proper judgments and grasp
YFT L YF T L YF TL YF TL L
YF T YF T L YFT L Y FT L YF T L YF T L L
YFT Y FT L YFT L YFT L YF TL



the concepts relevant to new drug therapies on the market.
YFT L YFT L YFT L YFT L L
YFT YF T L YF T L YF T L YFT L Y FT L




DIF: Application
REF: Role of the Dental Hygienist (Medication/Health History), Role of the Dental Hygienist
Y F T L YFT L YFTL YFT L L
YFT YFT L L
YFT YFTL YFT L YFTL YFTL YFT L



(Medication Administration), Role of the Dental Hygienist (Emergency Situations), Role of the Dental
L
YFT Y FT L YF T L YF T L YF TL Y FT L YF TL YFT L L
YF T YFT L Y FT L Y FT L YF TL



Hygienist (Nonprescription Medication) | pp. 2-3 OBJ:
YFT L 1 YF T L Y FT L YF TL YFT L YFT L



TOP: NBDHE, 6.0. Pharmacology Y F T L YFT L YFT L




2. Which of the following statements is true regarding planning appointments?
YFT L L
YFT YF T L YFT L YF T L Y FT L YFT L YFT L YFT L



a. Whether or not patients are taking medication for systemic diseases is of YFT L YFT L YFTL YF T L L
YFT YFT L YF T L YF T L YFT L YF T L YF T L



little YFT L



consequence in the dental office. YFT L L
YF T YFT L YF T L



b. Asthmatic patients should have dental appointments in the morning. YFT L YFT L YFT L YFT L Y FT L YFT L YFT L Y FT L



c. Diabetic patients usually have fewer problems with a morning appointment YFT L L
YFT L
YFT YFTL L
YFT L
YFT YFT L YFT L YFT L



compared with afternoon appointments.
YFT L YF T L YF T L YFT L



d. Both B and C are true. L
YFT YFT L YFTL L
YFT L
YFT




ANS: Y F T L D
Asthmatic patients who experience dental anxiety should schedule their appointments when they are YFT L L
YFT YFT L YFT L YFT L L
YFT YFTL L
YFT YFTL L
YFT L
YFT L
YFT




not rushed or under pressure early in the morning. Diabetic patients usually have relatively fewer
YFT L YFT L Y FT L YFT L YF TL YF T L Y FT L L
YF T Y FT L YFTL Y FT L YFT L Y FT L Y FT L L
YF T




problems with a morning appointment. Patients taking medication for systemic diseases may require
YFT L YFT L YFT L L
YFT YFT L L
YFT L
YFT L
YFT L
YFT L
YFT YFTL L
YFT L
YFT




special handling in the dental office.
YFT L Y FT L YF T L Y FT L YF T L YFT L




DIF: Comprehension
REF: Role of the Dental Hygienist (Appointment Scheduling)
Y F T L YFT L YFTL YFT L L
YFT YFT L YFT L



| p. 3 OBJ:
YFT L L YFT 1 TOP: NBDHE, 6.0. Pharmacology
YFT L YF T L Y F T L Y F T L YFT L YFT L

,3. Nutritional or herbal supplements YFT L YFT L YFTL



a. carry the U.S. Food and Drug Administration (FDA) approval for disease YFT L YFT L YFT L YFT L Y FT L YFT L Y FT L YFT L YF T L YFT L



states. YFTL


b. are not drugs. YFT L YFTL



c. can cause adverse effects. YFT L YFT L YF T L



d. will not interact with other drugs the patient may be taking. YFT L YFT L YFT L YFTL YFT L L
YF T YFT L L
YFT YFT L YFT L




ANS: Y F T L C
Nutritional or herbal supplements are quite capable of causing adverse effects. The majority of YFT L YFT L YFT L YFT L YFT L YFT L L
YFT YFT L YFT L YFT L L
YFT YFT L L
YFT




nutritional or herbal supplements do not carry FDA approval for treating disease states. These
YFT L YF TL YFT L Y FT L YF T L YFT L YFTL YF T L Y FT L YF TL YFT L YF T L YF T L L
YFT




supplements are drugs and can cause adverse effects and interact with different drugs.
YFT L YFT L YF T L YF T L Y FT L Y FT L L
YF T YF T L YFTL Y FT L YFT L Y FT L YFT L




DIF: Comprehension
REF: Role of the Dental Hygienist (Nutritional or Herbal Supplements)
Y F T L YFTL YFT L YFTL YFT L L
YFT YF T L YFTL YFT L



| p. 3 OBJ:
YFT L L YFT 1 TOP: NBDHE, 6.0. Pharmacology
YFT L YFT L Y F T L Y F T L YFT L L
YFT




4. Which type of drug name usually begins with a lowercase letter? YFT L YFT L YF TL YFT L Y FT L YFT L YF T L YF T L YF T L YFT L



a. Brand name YFT L



b. Code name YFTL



c. Generic name YFT L



d. Trade name L
YFT




ANS: Y F T L C
Before any drug is marketed, it is given a generic name that becomes the “official” name of the
YFT L YFT L YFT L L
YF T YFTL YFTL YFT L YFT L YFT L YFT L YFT L L
YFT L
YFT L
YFT YFT L L
YFT L
YFT




drug. Each drug is assigned only one generic name selected by the U.S. Adopted Name Council,
YFT L YFT L Y FT L YFT L Y FT L YF T L YFT L Y FT L YF TL YF T L YFT L Y FT L YF T L YFT L YFT L YF TL



and the name is not capitalized. The brand name is equivalent to the trade name and is
YFT L YF TL Y FT L YF T L YF T L YFT L YF T L Y FT L L
YF T Y FT L YFT L YFT L YFT L YFT L L
YFT L
YF T Y FT L



capitalized. Although the brand name is technically the name of the company marketing the
YFT L YFT L YF TL YFT L YFT L YFT L YFT L L
YFT YFT L YFT L L
YFT L
YFT YFT L YFT L



product, this term is often used interchangeably with the trade name. The code name is the initial
YFT L YFT L YFT L YFT L YFT L YFTL L
YF T YFT L YF T L YFT L YFT L YFT L YFT L YFT L Y FT L Y FT L YF T L



term used within a pharmaceutical company to refer to a drug while it is undergoing investigation
YFT L YF T L Y FT L L
YF T Y FT L Y FT L YF T L YFT L YF T L L
YFT YF T L YF T L YF T L YF T L L
YF T YF T L



and is often a combination of capital letters and numbers, the letters representing an abbreviation
YFT L YF TL YFT L YF TL YFT L YF T L Y FT L YF T L YFTL Y FT L L
YF T Y FT L YFTL YF TL Y FT L



of the company name.
YFT L Y FT L YF T L YFT L




DIF: Comprehension REF: Drug Names | Y F T L L
YFT L
YFT




p. 4 OBJ:
YFT L 3 TOP: L
YFT YFT L Y F T L Y F T L NBDHE, 6.0. Pharmacology YFT L L
YFT




5. A drug’s generic name is selected by the
YFT L Y FT L YFT L L
YFT L
YFT YFT L YFT L



a. pharmaceutical company manufacturing it. YFT L L
YFT YFTL



b. Food and Drug Administration (FDA). YFT L YF T L YFT L YF T L



c. U.S. Adopted Name Council. L
YFT L
YFT Y FT L



d. Federal Patent Office. YFT L YFT L




ANS: Y F T L C
Each drug is assigned only one generic name (e.g., ibuprofen). It is selected by the U.S. Adopted
L
YF T YF T L YF T L YF T L YF T L YF T L YFT L Y FT L L
YFT YFT L YFT L YF T L YFT L YF T L L
YF T YFT L



Name Council. The generic name is not selected by the FDA or the Federal Patent Office. The
YFT L YF T L Y FT L YFT L YF T L YF T L L
YF T YFT L YFT L YF T L Y FT L L
YF T YFT L YF T L YF T L L
YFT YFT L



pharmaceutical company manufacturing the drug clearly has an influence on the generic name given
YFT L YFT L YFT L L
YFT YFT L YFT L YFT L Y FT L YFT L YFT L L
YFT YFT L L
YFT L
YFT




its drug, but the final decision is not the company’s.
YFT L YF T L YFT L YFT L YFT L YF TL L
YF T YF TL L
YFT YF T L




DIF: Recall REF: Drug Names | p. 4 Y F T L L
YFT YF T L Y FT L YFT L OBJ:
Y 3 TOP:F T L YFT L Y F T L NBDHE, 6.0. Pharmacology YFT L L
YFT




6. Which of the following is true concerning generic and trade names of drugs?
YFT L YFT L YF T L YFTL YFT L YFT L YFT L YF T L L
YF T YFT L Y FT L YFT L



a. A drug may only have one generic name and one trade YFT L YFT L L
YFT YFT L YF TL L
YF T YF T L YF T L L
YF T Y FT L


YFT L name.

, b. A drug may only have one generic name, but it may have several trade
YFT L YFT L YFT L L
YFT YFT L Y FT L YFT L YF T L YF TL YF T L YFT L Y FT L YF T L



names. YFT L



c. A drug may have several generic names, but it may only have one trade
YFT L YFT L YFT L YF T L Y FT L L
YFT Y FT L YFT L L
YF T L
YFT L
YFT Y FT L YFTL



name. YFT L


d. A drug may have several generic names and several trade names.
YFT L YFTL YFT L YFT L Y FT L YFT L YFT L YF T L YF T L YFTL




ANS: Y F T L B
Each drug has only one generic name but may have several trade names. For each drug, there is
YF T L YF T L Y FT L YF TL Y FT L YF T L YF T L YFT L YF T L Y FT L Y FT L YFT L YFT L L
YFT YF T L YFT L YF T L



only one generic name. It is not capitalized, and it becomes the “official” name of the drug. The
YFT L Y FT L YF T L L
YF T YF T L YFT L YF T L YFT L YFT L L
YF T YF TL Y FT L YF T L YF T L YF T L YF T L L
YF T YFT L



pharmaceutical company discovering the drug gives the drug a trade name. The trade name is
YFT L YF TL YF T L Y FT L YF T L YFT L YF TL Y FT L YFT L Y FT L YFT L YF T L Y FT L YFT L YFT L



protected by the Federal Patent Law for 20 years from the earliest claimed filing date, plus patent
YFT L YFT L YFT L YFTL YF T L YFT L YFT L YFT L L
YFT YFT L L
YFT YFT L YFT L YFT L L
YFT YFT L L
YFT




term extensions. Although the brand name is technically the name of the company marketing the
YFT L YFT L L
YFT L
YFT YF T L L
YFT L
YFT YF T L YFT L YF T L YFT L L
YFT YF T L YFTL YFT L



product, it is often used interchangeably with the trade name.
YFT L L
YFT YFT L Y FT L YFT L YF T L Y FT L YF T L Y FTL YFT L




DIF: Comprehension REF: Drug Names | Y F T L L
YFT YFT L



p. 4 OBJ:
L
YFT 3 YFT LTOP: YFT L Y F T L Y F T L NBDHE, 6.0. Pharmacology YFT L YFT L




7. Two drugs that are found to be chemically equivalent, but not biologically equivalent
L
YFT YFT L YFTL YFT L YFT L YFT L L
YFT YFTL YFTL YFTL YFT L YFT L



YFT or therapeutically equivalent are said to differ in
L L
YFT Y FT L YFT L YFT L L
YF T YFT L YF T L



a. potency.
b. efficacy.
c. bioavailability.
d. therapeutic index. YFT L




ANS: Y F T L C
A preparation can be chemically equivalent yet not biologically or therapeutically equivalent.
YF T L Y FT L Y FT L YF TL L
YF T YFT L YFT L YFT L Y FT L YFT L YF T L



These products are said to differ in their bioavailability. The potency of a drug is a function of the
YFT L YF T L YFT L YFT L YFT L YFT L YFT L L
YFT L
YFT Y FT L L
YFT L
YFT YF T L YFT L L
YFT YF T L YFT L L
YFT L
YFT




amount of drug required to produce an effect. The efficacy is the maximum intensity of effect or
YFT L YFT L YF T L YF T L YF T L L
YFT YFT L L
YF T YFT L Y FT L L
YF T YFT L Y FT L YFT L Y FT L Y FT L YFT L



response that can be produced by a drug. The therapeutic index is the ratio of the lethal dose for
YFT L Y FT L YFT L YF T L YF T L YFT L YF T L Y FT L YFT L Y FT L Y FT L L
YF T YF TL Y FT L YFT L L
YF T Y FT L YF T L YF T L



50% of the experimental animals divided by the effective dose for 50% of the experimental
YFT L YFT L Y FT L YF T L Y FT L YFT L YF T L YFT L Y FT L YF T L YF T L YFTL YF T L Y FT L YF T L



animals. If the value of the therapeutic index is small, toxicity is more likely.
YFT L YFT L Y FT L YF T L YF T L YF TL YFT L Y FT L YF TL YF T L YF T L YF T L YF T L YFT L




DIF: Recall REF: Y F T L Drug Names (Drug Substitution) | L
YFT YFT L YFT L YFT L



p. 5 OBJ:
L
YFT 4YFT L Y FT L Y F T L TOP: Y F T L NBDHE, 6.0. Pharmacology YFT L YFT L




8. How many years must pass after a drug patent expires before other drug companies can market
YFT L YFT L YFT L L
YFT YFT L L
YFT YFT L YFT L YFT L YFTL YFT L L
YFT YFT L YFT L YFTL



YFT L the same compound as a generic drug?
L
YFT Y FT L YF T L YF T L YF T L Y FT L



a. 20 years Y FT L



b. 17 years Y FT L



c. 7 years Y FT L



d. 0 years Y FT L




ANS: Y F T L D
Once a drug patent expires, competing companies may immediately market the same compound in
YFT L Y FT L YFT L YFT L YFT L YF T L YFT L YFT L YF T L YFT L YF T L Y FT L L
YF T




generic form. The pharmaceutical company discovering the drug gives the drug a trade name. The
YFT L L
YF T YF TL YF T L YF T L YF T L YF T L Y FT L YFT L YFT L Y FT L YFT L YF T L L
YFT L
YF T




trade name is protected by the Federal Patent Law for 20 years from the earliest claimed filing date,
YFT L L
YFT YFT L YFT L YFT L YFT L YFT L YFT L YFT L YFT L YFTL Y FT L L
YFT YFTL YFT L YFTL L
YFT YFT L



plus the patent term extensions.
YFT L L
YF T YFT L YFT L Y FT L




DIF: Application REF: Y F T L Drug Names (Drug Substitution) | L
YFT YFT L YFT L YFT L



p. 5 OBJ:
L
YFT 4
YFT L Y FT L Y F T L TOP: Y F T L NBDHE, 6.0. Pharmacology YFT L YFT L